More Globe Newswire

View Older Stories View Newer Stories

Sep 8, 2026 07:00AM Del Taco Celebrates #1 Fast Food Honors With Free Tacos in Port St. Lucie
Sep 8, 2026 07:00AM Lightbridge Letter to Shareholders Outlines Expedited Pathway to Bring Lightbridge Fuel™ to Commercial Reactors
Sep 8, 2026 07:00AM Silicon Motion to Attend Upcoming Investor Conferences
Sep 8, 2026 07:00AM Lahontan Strengthens Technical, Engineering, and Business Development Team
Sep 8, 2026 07:00AM NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
Sep 8, 2026 07:00AM CoinShares Co-Founder and Non-Executive Director Daniel Masters Adopts Pre-Scheduled Trading Plan
Sep 8, 2026 07:00AM X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting
Sep 8, 2026 07:00AM Cartesian Therapeutics Announces New Employment Inducement Grants
Sep 8, 2026 07:00AM Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics
Sep 8, 2026 07:00AM CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026 07:00AM G3 Goldfields Provides Update on Listing
Sep 8, 2026 07:00AM Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Sep 8, 2026 07:00AM Phoenix Metals Receives Amended Exploration Permit and Accelerates Phase 1 Drill Program at Greenwood
Sep 8, 2026 07:00AM Rigetti Signs Definitive Agreement for $100M with U.S. Government to Accelerate R&D for Superconducting Quantum Computing
Sep 8, 2026 07:00AM Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer
Sep 8, 2026 07:00AM Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis
Sep 8, 2026 07:00AM BrainChild Bio Closes $116 Million Series A Financing
Sep 8, 2026 07:00AM Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
Sep 8, 2026 07:00AM Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
Sep 8, 2026 07:00AM NetraMark Appoints Former Global Atlantic Investment Office President and Scotiabank U.S. CEO Kevin Felix as Strategic Advisor
Sep 8, 2026 07:00AM BrewDog Roars into Rugby with Five-Year Leicester Tigers Partnership, Bringing Punk Energy to Welford Road
Sep 8, 2026 07:00AM Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Sep 8, 2026 07:00AM OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
Sep 8, 2026 07:00AM Beamr and VAST Data Partner to AI-enhance and Monetize Video Archives with NVIDIA
Sep 8, 2026 07:00AM Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
Sep 8, 2026 07:00AM NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
Sep 8, 2026 07:00AM DraftKings Extends Agreement with IC360 to Enhance Integrity Monitoring and Combat Athlete Harassment Across Sportsbook and Prediction Market Platforms
Sep 8, 2026 07:00AM Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
Sep 8, 2026 07:00AM Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
Sep 8, 2026 07:00AM Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
Sep 8, 2026 07:00AM LiveU, AP bring new connectivity, workflow tech to global newsgathering, deploying largest LU900Q fleet worldwide
Sep 8, 2026 07:00AM Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics
Sep 8, 2026 07:00AM Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development
Sep 8, 2026 07:00AM CoinShares Co-Founder and Non-Executive Director Daniel Masters Adopts Pre-Scheduled Trading Plan
Sep 8, 2026 06:58AM ABM Reports Fiscal Third Quarter 2026 Results
Sep 8, 2026 06:55AM YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
Sep 8, 2026 06:55AM YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
Sep 8, 2026 06:50AM Treno Scope Launches Liquidity Analysis Module, with Initial Focus on the Indonesian Market
Sep 8, 2026 06:50AM Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks
Sep 8, 2026 06:45AM Bullish releases August 2026 monthly metrics
Sep 8, 2026 06:42AM 2026 CIFTIS Culture and Tourism Services Section Media Briefing Held in Beijing
Sep 8, 2026 06:30AM DPM Metals Extends Mineralization at Dumitru Potok with High-Grade Intercepts
Sep 8, 2026 06:30AM Zacatecas Silver Announces Multiple Silver Assays from El Cristo Drill Program
Sep 8, 2026 06:30AM Nova Minerals’ Marches towards Antimony Production with Arrival of Processing & Refining Equipment in Alaska
Sep 8, 2026 06:30AM Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
Sep 8, 2026 06:30AM Four Rigs Now Turning at Pecoy
Sep 8, 2026 06:30AM UK’s MHRA Accepts Biosplice’s Application for Lorecivivint (LOR) in Knee Osteoarthritis and Begins Assessment
Sep 8, 2026 06:30AM Prana Therapies Announces Positive Phase 1 Results for PRA-216, a Novel IL-4Rα/TSLP Bispecific Antibody, Supporting Its Potential Best-in-Disease Profile and Providing the First Clinical Validation o
Sep 8, 2026 06:30AM Nova Minerals’ Marches towards Antimony Production with Arrival of Processing & Refining Equipment in Alaska
Sep 8, 2026 06:30AM FTC Solar to Participate in Upcoming Investor Events
View Newer Stories View Older Stories